{
    "clinical_study": {
        "@rank": "33467", 
        "arm_group": [
            {
                "arm_group_label": "IV infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "Oxytocin 10 IU will be administered by IV infusion according to randomization assignment as soon as possible after delivery of the baby."
            }, 
            {
                "arm_group_label": "IV bolus", 
                "arm_group_type": "Active Comparator", 
                "description": "Oxytocin 10 IU will be administered by IV bolus according to randomization assignment as soon as possible after delivery of the baby."
            }, 
            {
                "arm_group_label": "IM injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Oxytocin 10 IU will be administered by IM injection according to randomization assignment as soon as possible after delivery of the baby."
            }
        ], 
        "brief_summary": {
            "textblock": "The study will evaluate whether prophylactic oxytocin administered in the third stage of\n      labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage\n      compared to intramuscular (IM) injection."
        }, 
        "brief_title": "Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Postpartum Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will compare the effect of IV infusion or IV bolus to IM oxytocin administration\n      with respect to mean blood loss and the proportion of women who experience blood loss\n      greater than or equal to 500 ml, women who experience blood loss greater than or equal to\n      350 ml, side effects, adverse events and change in hemoglobin pre- to post-delivery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All women who present in active labor for a live birth at the study hospital will be\n             considered for participation in the study\n\n        Exclusion Criteria:\n\n          -  Planned or transferred for delivery via Cesarean section\n\n          -  Administration of a pre-delivery uterotonic to induce or augment labor\n\n          -  Unable to provide informed consent due to mental impairment, distress during labor or\n             other reason"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "4900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914419", 
            "org_study_id": "3000a"
        }, 
        "intervention": {
            "arm_group_label": [
                "IV infusion", 
                "IV bolus", 
                "IM injection"
            ], 
            "intervention_name": "Oxytocin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Postpartum hemorrhage", 
            "Oxytocin", 
            "Prevention", 
            "Third stage of labor", 
            "Hemoglobin", 
            "Intravenous", 
            "Intramuscular", 
            "Bolus"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": [
            {
                "contact": {
                    "email": "edarwish@hotmail.com", 
                    "last_name": "Emad Darwish, MD", 
                    "phone": "2034860665"
                }, 
                "facility": {
                    "address": {
                        "city": "Alexandria", 
                        "country": "Egypt"
                    }, 
                    "name": "Shatby Maternity Hospital, Alexandria University"
                }, 
                "investigator": {
                    "last_name": "Emad Darwish, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mshereen57@yahoo.com", 
                    "last_name": "Mohammed Cherine Ramadan, MD", 
                    "phone": "2023387667"
                }, 
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "El Galaa Teaching Hospital"
                }, 
                "investigator": {
                    "last_name": "Mohammed Cherine Ramadan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "Administration of Oxytocin Via Intramuscular Injection and Intravenous Bolus or Intravenous Infusion in the Third Stage of Labor for Prevention of Postpartum Hemorrhage", 
        "overall_contact": {
            "email": "rdabash@gynuity.org", 
            "last_name": "Rasha Dabash, MPH", 
            "phone": "212-448-1230"
        }, 
        "overall_contact_backup": {
            "email": "hanger@gynuity.org", 
            "last_name": "Holly A Anger, MPH", 
            "phone": "212-448-1230"
        }, 
        "overall_official": [
            {
                "affiliation": "Gynuity Health Projects", 
                "last_name": "Beverly Winikoff, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Gynuity Health Projects", 
                "last_name": "Rasha Dabash, MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Gynuity Health Projects", 
                "last_name": "Ilana Dzuba, MHS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Gynuity Health Projects", 
                "last_name": "Jill Durocher", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Gynuity Health Projects", 
                "last_name": "Jennifer Blum, MPH", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Postpartum blood loss equal to or greater than 500 mL as measured in a plastic, calibrated container.", 
            "measure": "Proportion of women with postpartum blood loss equal to or greater than 500 mL", 
            "safety_issue": "No", 
            "time_frame": "1 hour after delivery of baby"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914419"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Mean blood loss as measured in a plastic, calibrated container.", 
                "measure": "Mean postpartum blood loss", 
                "safety_issue": "No", 
                "time_frame": "1 hour after delivery of the baby"
            }, 
            {
                "description": "Postpartum blood loss equal to or greater than 500 mL as measured in a plastic, calibrated container.", 
                "measure": "Proportion of women with postpartum blood loss equal to or greater than 350 mL", 
                "safety_issue": "No", 
                "time_frame": "1 hour after delivery of the baby"
            }, 
            {
                "description": "Postpartum blood loss equal to or greater than 1000 mL as measured in a plastic, calibrated container.", 
                "measure": "Proportion of women with postpartum blood loss equal to or greater than 1000 mL", 
                "safety_issue": "No", 
                "time_frame": "1 hour after delivery"
            }, 
            {
                "description": "Hemoglobin will be measured in g/dL using the Hemocue machine. Pre-delivery hemoglobin will be taken during labor.", 
                "measure": "Mean change in hemoglobin pre-delivery to postpartum", 
                "safety_issue": "No", 
                "time_frame": "At least 12 hours after removal of IV and within 48 hours of delivery of the baby"
            }, 
            {
                "description": "Time interval in minutes between delivery of the baby and delivery of the placenta", 
                "measure": "Time to delivery of placenta", 
                "safety_issue": "No", 
                "time_frame": "Within 1 hour of delivery of the baby"
            }, 
            {
                "measure": "Administration of additional oxytocin, other uterotonics or other interventions such as blood transfusion or hysterectomy", 
                "safety_issue": "No", 
                "time_frame": "Within 1 hour of delivery of the baby"
            }, 
            {
                "measure": "Side effects 1 hour postpartum", 
                "safety_issue": "No", 
                "time_frame": "1 hour after delivery of the baby"
            }
        ], 
        "source": "Gynuity Health Projects", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "El Galaa Teaching Hospital, Cairo, Egypt", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Faculty of Medicine, University of Alexandria", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Gynuity Health Projects", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}